Explorez tous les épisodes du podcast NYU Langone Insights on Psychiatry
| Titre | Date | Durée | |
|---|---|---|---|
| The State of Precision Psychiatry | 19 Dec 2025 | 00:12:56 | |
To kick off Season 4, Charles Marmar, MD, explains how precision psychiatry is reshaping the way clinicians and researchers think about diagnosis, treatment selection, and the underlying biology of psychiatric disorders. This conversation is a overview of where the field stands today—including emerging molecular markers, biologically informed subtypes, and new translational approaches inspired by oncology and other precision-based specialties. Dr. Marmar is Chair of Psychiatry at NYU Grossman School of Medicine, and Director of the Center for the Study of Alcohol Use Disorder and Traumatic Stress. ▶️ Watch Insights on Psychiatry on YouTube In this episode, Dr. Marmar outlines current work on:
This discussion reflects ongoing efforts at NYU Langone Health to move psychiatry toward a more mechanism-based, biologically grounded model of care, while acknowledging the complexity and early stage of the work. This episode is intended for psychiatrists, mental health clinicians, and others interested in the treatment of complex psychiatric disorders. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| The Next Big Breakthrough | 21 May 2025 | 00:43:30 | |
What if mental health care worked more like cancer treatment—tailored to the individual, informed by biology, and driven by data? Charles Marmar, MD, Chair of Psychiatry at NYU Grossman School of Medicine, takes us through the latest advances in precision psychiatry. From brain imaging to digital phenotyping, Dr. Marmar outlines the tools shaping a future where treatment is fully customized. He also shares stories from the front lines: a patient whose depression was treated with the help of a brain biopsy, why PTSD and depression aren’t one-size-fits-all, and how quantum computing could radically accelerate psychiatric research. 🔍 Topics Covered 00:00 Introduction 📚 Related Resources Charles Marmar, MD – NYU Faculty Profile 🙌 Support & Subscribe If this episode challenged your thinking, like, share, and subscribe to help bring smart, science-forward conversations to a wider audience. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Pediatric ADHD: A Lifespan Approach (with Timothy Wilens, MD) | 09 Apr 2024 | 00:43:37 | |
Dr. Timothy Wilens is a Professor of Psychiatry at Harvard Medical School and Chief of the Division of Child and Adolescent Psychiatry at Massachusetts General Hospital. His research interest include the relationship between ADHD, bipolar disorder, and substance use disorders; ADHD pharmacotherapy; and stimulant medication misuse. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Schizophrenia (with Ira Glick, MD) | 02 Apr 2024 | 00:36:02 | |
Dr. Ira Glick is Professor Emeritus of Psychiatry and Behavioral Sciences at Stanford University Medical Center, where he has served as director of the Schizophrenia Research Clinic. On this episode, he discusses his research journey, which began in the 1960s and followed a shift from psychoanalysis to biological psychiatry. He addresses the broken social safety net for schizophrenia patients, including the controversial topic of treating some patients against their will, as well as the challenges of medication adherence, and the stigma surrounding severe mental illness. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Mental Health Equity (with Christin Drake, MD) | 26 Mar 2024 | 00:40:47 | |
Dr. Christin Drake is Clinical Associate Professor and Vice Chair of Diversity and Equity in the Department of Psychiatry at NYU Grossman School of Medicine. On this episode, Dr. Drake discusses ongoing efforts to improve mental health equity, including by improving psychiatric services for underserved groups, gathering better data, and boosting diversity among health care providers. She also discusses the importance of integrating mental health care into perinatal services and challenges the conventional wisdom about stigma toward mental health care in the Black community. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Ketamine (with John Krystal, MD) | 19 Mar 2024 | 00:42:48 | |
Dr. John Krystal is Chair of Psychiatry at the Yale School of Medicine. He is best known for leading the discovery of the rapid antidepressant effects of ketamine, which paved the way for the first major new antidepressant drug in decades. Here, Dr. Krystal talks about what we’ve learned in the five years since esketamine nasal spray was approved by the FDA, including efforts to predict treatment response, dosage and frequency, safety, and long-term impact. He also discusses advances in our understanding of alcohol use disorder and weighs in on the search for psychiatric biomarkers. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Struggling Kids & Teens (with Robert Findling, MD) | 12 Mar 2024 | 00:45:53 | |
Dr. Robert Findling is Chair of the Department of Psychiatry at the Virginia Commonwealth University School of Medicine. Here he discusses recent advances in pediatric mental health, including his own research on aggression and schizophrenia in young people. Dr. Findling also shares his thoughts on the crisis of teen suicide, the lingering impact of COVID-19 on children’s mental health, and the need for early and collaborative interventions. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Frontiers of Psychopharmacology (with Charles Nemeroff, MD, PhD) | 05 Mar 2024 | 00:49:54 | |
Dr. Charles Nemeroff is Chair of the Department of Psychiatry and Behavioral Sciences at the University of Texas-Austin's Dell Medical School. He is also co-director of the Center for Psychedelic Research and Therapy, and director of the Institute for Early Life Adversity Research. His research is focused on the pathophysiology of mood and anxiety disorders with a focus on the role of child abuse and neglect as a major risk factor. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Empathy Training (with Helen Riess, MD) | 27 Feb 2024 | 00:45:29 | |
Dr. Helen Riess is Associate Clinical Professor of Psychiatry at Harvard Medical School and Director of Empathy Research and Training in the Psychotherapy Research Group at Massachusetts General Hospital. She is also Founder and Chief Executive Officer at Empathetics, a company that provides science-based empathy and interpersonal skills training for healthcare professionals. Her research focuses on improving empathy and relational skills in physicians. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Obsessive-Compulsive Disorder (with Christopher Pittenger, MD, PhD) | 20 Feb 2024 | 00:51:15 | |
Dr. Christopher Pittenger is a Professor of Psychiatry at the Yale School of Medicine and Director of the Yale OCD Research Clinic. In this episode, he discusses the neurobiology, symptomology, and treatment of Obsessive-Compulsive Disorder (OCD), including potential new treatments such as psychedelics, neurofeedback, glutamate modulators, and transcranial magnetic stimulation (TMS). This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Meditation (with Richard Davidson, PhD) | 13 Feb 2024 | 00:37:39 | |
Dr. Richard Davidson is the William James and Vilas Professor of Psychology and Psychiatry at the University of Wisconsin–Madison and Founder & Director of the Center for Healthy Minds. In this episode, he discusses the current state of research on mindfulness and meditation as mental health interventions. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Precision Psychiatry (with Ronald Kessler, PhD) | 06 Feb 2024 | 00:46:23 | |
Dr. Ronald Kessler is the McNeil Family Professor of Health Care Policy at Harvard Medical School. His groundbreaking work on the social determinants of mental health, studied from an epidemiological perspective, has made him the most widely cited psychiatric researcher in the world. In this wide-ranging conversation, he talks about precision psychiatry's enormous potential and incremental development, delving into his own efforts to better identify at-risk patients and predict treatment efficacy. Dr. Kessler stresses the need for better data and bigger studies, and envisions a future of AI-supported clinicians. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| The Schizophrenia Puzzle is Solvable | 14 May 2025 | 00:38:51 | |
There’s a care model for schizophrenia that actually works—why isn’t it everywhere? On this episode, W. Gordon Frankle, MD, MBA, Vice Chair of Psychiatry at NYU Langone Health, shares how his team in Brooklyn is building a new model for treating serious mental illness—one rooted in long-term, relationship-driven, team-based care. From wraparound services to precision psychiatry, this conversation explores what happens when you bring humanity, structure, and innovation to a population too often left behind. Also discussed:
🔍 Topics Covered 00:00 Introduction 📚 Related Resources W. Gordon Frankle, MD, MBA If you enjoyed this episode, please like, share, and subscribe to support real conversations about transforming mental health care. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Addiction (with Petros Levounis, MD, MA) | 30 Jan 2024 | 00:36:10 | |
Dr. Petros Levounis is President of the American Psychiatric Association and a leader in addiction research. He joins host Thea Gallagher, PsyD, to talk about the latest in addiction medicine, the state of the opioid crisis, the growing problem of technology addiction, and the promise and risks of psychedelic medicine. He also shares his hopes for the future of psychiatry, including better integration of diagnoses, treatments, and outcomes for people with mental health disorders. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Season 2 Announcement | 30 Oct 2023 | 00:00:26 | |
Starting this fall, we're releasing 12 more conversations with the best minds in psychiatry. Subscribe wherever you're listening, so you won't miss an episode. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Biomarkers for Depression (with Carla Nasca, PhD) | 18 Jul 2023 | 00:34:43 | |
Dr. Carla Nasca is an Assistant Professor in the Department of Psychiatry and the Department of Neuroscience and Physiology at NYU Langone, where she studies epigenetic mechanisms of neuroplasticity to stress. Dr. Nasca's work led to the discovery of acetyl-L-carnitine (LAC), a metabolite found in the mitochondria, as a promising biological marker of depression.
More information: https://www.cdr.rfmh.org/research/nasca-lab/ This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Dopamine (with Tanya Sippy, MD, PhD) | 06 Jul 2023 | 00:44:42 | |
Dr. Tanya Sippy is an Assistant Professor in the Department of Psychiatry and the Department of Neuroscience and Physiology at NYU Langone. She’s also Principal Investigator at the Sippy Lab and Associate Director of the Psychedelic Medicine Research Training Program. Her research explores the neural mechanisms that underlie how sensory stimuli become associated with goal-directed behavior.
More information: https://www.sippylab.com/ This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Bipolar Disorder (with Andrew Nierenberg, MD) | 20 Jun 2023 | 00:38:17 | |
Dr. Andrew Nierenberg is a Professor of Psychiatry at Harvard Medical School and Director of the MGH Dauten Family Center for Bipolar Treatment Innovation. He completed his residency in psychiatry at New York University/Bellevue Hospital.
More information: This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Depressive Disorders (with Alan Schatzberg, MD) | 08 Jun 2023 | 00:46:48 | |
Dr. Alan Schatzberg is a Professor of Psychiatry and Behavioral Sciences at Stanford Medicine, and Director of the Stanford Mood Disorders Center. His research examines the biology and psychopharmacology of depressive disorders. An NYU School of Medicine alumnus, Dr. Schatzberg was President of the American Psychiatric Association from 2009-2010.
For more information: This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Psychedelic Medicine (with Michael Bogenschutz, MD) | 23 May 2023 | 00:48:03 | |
Dr. Michael Bogenschutz is a Professor of Psychiatry at the NYU Grossman School of Medicine, and Director of the NYU Langone Center for Psychedelic Medicine.
Cited: For more information: This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Sleep and Alzheimer's Disease (with Omonigho M. Bubu, MD, MPH, PhD) | 09 May 2023 | 00:38:08 | |
Dr. Omonigho M. Bubu is an Assistant Professor of Psychiatry and Population Health at the NYU Grossman School of Medicine, where he studies the connection between sleep and neurodegenerative diseases, as well as social determinants of health as they relate to cognitive health. In this interview, he discusses the importance of sleep, especially for people at higher risk of developing Alzheimer’s disease. Topics:
Visit our website for more information: This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Mindfulness-Based Stress Reduction (with Naomi Simon, MD) | 21 Apr 2023 | 00:36:13 | |
Naomi Simon, MD, talks about her research into mindfulness-based stress reduction (MBSR) and yoga as treatments for anxiety disorders. Dr. Simon is a Professor in the Department of Psychiatry at the NYU Grossman School of Medicine, and Director of the Anxiety, Stress, and Prolonged Grief Program. Topics:
Cited: Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders (Nov. 2022) This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Fear Conditioning (with Mohammed Milad, PhD) | 11 Apr 2023 | 00:41:56 | |
Mohammed Milad, PhD, discusses recent research into fear conditioning, regulation, and extinction. Dr. Milad is a Professor in the Department of Psychiatry at the NYU Grossman School of Medicine and Director of the Behavioral Neuroscience Program.
This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| How Psychedelics Rewire the Brain | 07 May 2025 | 00:32:11 | |
How could a single psychedelic treatment cause lasting change? Joshua Siegel, MD, PhD, is on a mission to find out. A leading expert on neuroimaging and neuropsychopharmacology at NYU Langone’s Center for Psychedelic Medicine, Dr. Siegel unpacks how psilocybin may spark neuroplasticity and reshape the depressed brain. He also gives us an inside look at the race to develop non-hallucinogenic psychedelic analogs. Dr. Siegel is an assistant professor at NYU Grossman School of Medicine. 🔍 Topics Covered: 00:00 Introduction Joshua Siegel, MD, PhD 🔔 Don’t forget to subscribe for more interviews with top psychiatric researchers. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Health Equity (with Ayana Jordan, MD, PhD) | 17 Mar 2023 | 00:52:35 | |
Ayana Jordan, MD, PhD, is the Barbara Wilson Associate Professor of Psychiatry at the NYU Grossman School of Medicine, an Associate Professor in the Department of Population Health, and the Pillar Lead for the Institute for Excellence in Health Equity.
This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Adult ADHD (with Lenard Adler, MD) | 23 Feb 2023 | 00:33:29 | |
Lenard A. Adler, MD, is a Professor of Psychiatry and Child and Adolescent Psychiatry at the NYU Grossman School of Medicine and Director of the Adult ADHD Program at NYU Langone Health. Topics covered:
This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Treatment-Resistant Depression (with Dan Iosifescu, MD) | 21 Feb 2023 | 00:29:22 | |
Dan Iosifescu, MD, is an Associate Professor of Psychiatry at the NYU Grossman School of Medicine and director of clinical research at the Nathan Kline Institute for Psychiatric Research. His research has led to the validation of novel treatments for patients with severe mood and anxiety disorders, including pharmacological treatments such as ketamine and other glutamatergic drugs, and devices such as novel forms of magnetic stimulation.
This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| PTSD & Precision Medicine (with Charles Marmar, MD) | 17 Feb 2023 | 00:45:56 | |
Charles R. Marmar, MD, is the Peter H. Schub Professor of Psychiatry and Chair of the Department of Psychiatry at NYU Langone Health. He also serves as Director of the Center for Precision Medicine in Alcohol Use Disorders and Post-Traumatic Stress Disorder (PTSD) and as Executive Director of the Steven A. Cohen Military Family Center.
Internationally renowned for his expertise in PTSD for over 25 years, Dr. Marmar's focus ranges from combat-related conditions in military veterans to PTSD in refugees and earthquake victims. He has served on multiple committees and scientific advisory groups at the national level for both the Department of Veterans Affairs and the National Institute of Mental Health (NIMH) and as counsel to the VA Medical Centers, fire departments, disaster response teams and police departments, including the NYPD. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Can AI Help Prevent PTSD? | 30 Apr 2025 | 00:30:06 | |
What if a simple conversation in the emergency room could reveal who’s most at risk for PTSD before symptoms even begin? Katharina Schultebraucks, PhD, shares her innovative work on using machine learning to forecast mental health outcomes and explains how AI could revolutionize how we detect, prevent, and treat psychiatric disorders. Dr. Schultebraucks is Co-Director of the Computational Psychiatry Program and Associate Professor in the Department of Psychiatry and Population Health at NYU Grossman School of Medicine. 🔍 Topics Covered 📚 Related Resources 🔔 Subscribe for more conversations at the intersection of mental health and innovation. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| ADHD at School: What Actually Helps | 23 Apr 2025 | 00:29:46 | |
How do you help a child with ADHD stay organized, on task, and confident in school? Richard Gallagher, PhD, a child and adolescent psychologist at NYU Langone Health, shares groundbreaking research on organizational skills training for children with ADHD—a behavioral treatment that’s changing lives and improving classroom performance. This episode dives into how executive functioning challenges manifest in real life, the strengths (and limits) of technology, and the power of parent training and therapeutic coaching to help children thrive. Dr. Richard Gallagher is Associate Professor in the Department of Child and Adolescent Psychiatry at NYU Grossman School of Medicine, and Director of the Organization Skills Program. 🔍 Topics Covered 00:00 Introduction 📚 Related Resources 👨⚕️More about Dr. Richard Gallagher 🙌 Support & Engage If this episode was helpful, please like, share, and subscribe to support the series and spread awareness about evidence-based ADHD care. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| The Hidden Adult ADHD Crisis | 16 Apr 2025 | 00:35:33 | |
ADHD isn’t just a childhood condition—many adults go undiagnosed for years. Lenard Adler, MD, Director of the Adult ADHD Program at NYU Langone Health, breaks down the nuances of ADHD in adults, the challenges of proper diagnosis, and the latest treatments available. Learn about his research, the screening tools his team has developed, and what’s on the horizon for adult ADHD care. 🔍 Topics Covered: 00:00 Introduction 📚 Related Resources:
🙌 Support & Engage: If you found this episode helpful, please like, comment, and share to spread awareness. 🔔 Don’t forget to subscribe to stay updated on new episodes. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| How to Make Addiction Care Routine | 09 Apr 2025 | 00:29:10 | |
Despite affecting more Americans than diabetes, substance use is often left out of routine medical care. In this episode, NYU Langone Health’s Jennifer McNeely, MD—a clinician investigator, primary care and addiction medicine physician—explains why that must change. From the surprising history behind addiction’s exclusion from mainstream medicine to the innovative screening tools shaping the future of care, this conversation is a must-listen for anyone interested in addiction care and healthcare policy. Jennifer McNeely, MD, is an Associate Professor of Medicine and Population Health at NYU Grossman School of Medicine and co-director of the Section on Tobacco, Alcohol, and Drug Use. 🔍 Topics Covered: 00:00 – Introduction 📚 Related Resources: Jennifer McNeely, MD 🙌 Support & Engage: If you found this episode helpful, please like, comment, and share to spread awareness. 🔔 Don’t forget to subscribe to stay updated on new episodes. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| The Key to Effective Addiction Care | 02 Apr 2025 | 00:34:02 | |
What makes addiction treatment truly effective? Behavioral scientist Charles Neighbors, MBA, PhD, shares groundbreaking research on the importance of therapeutic relationships, harm reduction, and human connection—love!—in treating substance use disorders. Dr. Neighbors is an Associate Professor in the Departments of Population Health, and Psychiatry at NYU Grossman School of Medicine. 💡 Topics Covered 00:00 Introduction to Dr. Charles Neighbors 📚 Related Resources
🔔 Subscribe for more insights on mental health & addiction treatment! 👍 If you found this video helpful, please like, comment, and share to spread awareness! This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Pediatric ADHD: Precision Strategies (with Samuele Cortese, MD, PhD) | 16 Apr 2024 | 00:40:06 | |
For the final episode of Season 2, we're joined by Dr. Samuele Cortese, Professor of Child and Adolescent Psychiatry at the University of Southampton (UK) and Adjunct Full Professor at NYU Langone. Together we explore the intersection of pediatric ADHD and precision psychiatry, including the disorder’s genetic underpinnings and evolving treatment options. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Interventional Approaches to Treatment-Resistant Mood Disorders | 26 Dec 2025 | 00:19:11 | |
Joshua Berman, MD, PhD, discusses how careful evaluation, patient priorities, and risk-benefit tradeoffs guide the use of interventional treatments when conventional approaches fall short. Dr. Berman also explains how tools such as ketamine, TMS, ECT, and neurofeedback can be used strategically—sometimes in sequence or combination—to address different vulnerabilities within mood-related brain circuits. Dr. Berman is Associate Professor of Psychiatry and Director of Interventional Psychiatry at NYU Langone Health. ▶️ Watch Insights on Psychiatry on YouTube 00:47 What Is Interventional Psychiatry? This episode is intended for psychiatrists, mental health clinicians, and others interested in interventional approaches to complex psychiatric disorders. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Bipolar Depression and Mixed Episodes: Rethinking Treatment Goals | 02 Jan 2026 | 00:23:20 | |
Dan Iosifescu, MD, discusses why bipolar depression and mixed episodes remain among the most difficult—and highest-risk—conditions in psychiatry. Even when mood symptoms improve, many patients continue to experience significant cognitive and functional impairment. Dr. Iosifescu argues that standard approaches often fall short because symptom suppression is mistaken for recovery, short-term improvement is confused with durable treatment, and mixed episodes expose the limits of one-size-fits-all care. The conversation explores the clinical dangers of mixed episodes, the challenge of recognizing them, and the importance of moving deliberately from acute stabilization to sustainable long-term treatment. Dan Iosifescu, MD, is Director of Clinical Research at the Nathan Kline Institute and Director of the Mood Disorders Clinical and Research Program at NYU Langone Health. ▶️ Watch Insights on Psychiatry on YouTube 00:33 Introduction This episode is intended for psychiatrists, mental health clinicians, and others interested in treatment-resistant forms of depression and bipolar disorder. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Delivering Addiction Care Outside Traditional Settings | 12 Jan 2026 | 00:17:06 | |
Ayana Jordan, MD, PhD, discusses how precision psychiatry must expand beyond biology to address the social, cultural, and structural realities shaping addiction and mental health care for historically underrepresented patients. The conversation explores how trauma, poverty, housing instability, health literacy, and stigma interact with substance use and serious mental illness—and why traditional clinic-based models often fail to meet patients where they are. Dr. Jordan describes the work of the Jordan Wellness Collaborative, including partnerships that integrate addiction treatment into primary care, community settings, and faith-based institutions. She explains how peer facilitators, housing support, and trusted community spaces can dramatically improve engagement, retention, and outcomes. Looking ahead, she reflects on how emerging tools—from AI-supported care models to novel treatments for addiction—may further transform access and equity in psychiatric care. Ayana Jordan, MD, PhD, is the Barbara Wilson Professor of Psychiatry at NYU Grossman School of Medicine and Principal Investigator of the Jordan Wellness Collaborative. ▶️ Watch Insights on Psychiatry on YouTube TOPICS
This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Treating ADHD in Patients With Bipolar Disorder and Substance Use | 19 Jan 2026 | 00:21:04 | |
Lenard Adler, MD, explains how clinicians can safely and effectively treat ADHD when bipolar disorder and addiction are also in the picture. He addresses how to distinguish chronic ADHD symptoms from episodic mood disorders, why bipolar disorder is often missed in adults referred for depression or attention problems, and how substance use complicates both diagnosis and medication selection. Dr. Adler also shares guidance on identifying red flags for diversion or misuse, setting appropriate expectations for medication trials, and navigating the limits of current treatment guidelines. The episode closes with a look toward emerging directions in ADHD treatment, including research on emotional dysregulation, executive function deficits, and next-generation neurofeedback approaches. Lenard Adler, MD, is Pottash Professor of Psychiatry and Director of the Adult ADHD Program at NYU Langone Health ▶️ Watch Insights on Psychiatry on YouTube 00:00 Why ADHD, Bipolar Disorder, and Addiction Must Be Treated Together This episode is intended for psychiatrists, mental health clinicians, and others interested in complex adult ADHD presentations. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Psychedelics for Treatment-Resistant Disorders | 26 Jan 2026 | 00:16:28 | |
Michael Bogenschutz, MD, explains how psychedelic-assisted treatments may offer new options for patients with severe, treatment-refractory psychiatric conditions. He discusses why standard approaches often fall short for complex cases, how psychedelics like psilocybin and MDMA differ from conventional medications, and what careful screening and clinical structure make these treatments safe and effective. Drawing on randomized clinical trials and years of clinical experience, Dr. Bogenschutz describes how psychedelic treatments can produce durable symptom improvement in disorders such as alcohol use disorder and trauma-related conditions. He also explores unresolved scientific questions, including whether the psychedelic experience itself is necessary for therapeutic benefit. Michael Bogenschutz, MD, is Professor of Psychiatry and Director of the Center for Psychedelic Medicine at NYU Langone Health. ▶️ Watch Insights on Psychiatry on YouTube 00:00 A Remarkable Case: Sustained Sobriety After Psilocybin Treatment This episode is intended for psychiatrists, mental health clinicians, and others interested in complex and treatment-resistant psychiatric conditions. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| The Neuropsychiatry of Complex Brain Injury Care | 02 Feb 2026 | 00:18:11 | |
Lindsey Gurin, MD, discusses how clinicians can approach patients whose symptoms fall at the intersection of psychiatry and neurology. Drawing on her work with traumatic brain injury, PTSD, and persistent post-concussive symptoms, she explains why attempts to separate psychological trauma from neurological injury often obscure what patients actually need. The conversation explores identity disruption after brain injury, the unintended effects of rigid recovery timelines, and the importance of continuity in understanding symptoms over time. Dr. Gurin also discusses how neurodevelopmental traits such as ADHD shape vulnerability and treatment response, when stimulant medications can be appropriate after concussion, and why breaking complex presentations into treatable components often matters more than assigning a single diagnosis. Lindsey Gurin, MD, is Assistant Professor in the Departments of Neurology, Psychiatry, and Rehabilitation Medicine at NYU Langone Health, and Director of the Neurology/Psychiatry Residency Program. ▶️ Watch Insights on Psychiatry on YouTube 00:00 Brain Injury and Identity This episode is intended for psychiatrists and other clinicians caring for patients with complex neuropsychiatric presentations at the intersection of psychiatry and neurology. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Diagnosing Autoimmune Psychosis | 09 Feb 2026 | 00:11:41 | |
Katlyn Nemani, MD, explores how autoimmune and inflammatory brain disorders can present as first-episode psychosis—and why some patients diagnosed with schizophrenia may actually have a treatable immune-mediated illness. She explains the clinical features that should prompt suspicion for autoimmune psychosis, including subacute onset, subtle neurologic signs, and poor response to antipsychotics, even when standard imaging and antibody tests are unrevealing. Dr. Nemani also discusses the limits of current biomarkers, how to think clinically when diagnostic certainty is incomplete, and why early immunotherapy can dramatically alter outcomes. The conversation closes with a forward-looking discussion of emerging research suggesting that a meaningful subset of schizophrenia-like illness may ultimately be reclassified as autoimmune in origin. Katlyn Nemani, MD, is a Research Assistant Professor in the Departments of Psychiatry and Neurology at NYU Grossman School of Medicine and a graduate of NYU’s combined Neurology-Psychiatry residency program. ▶️ Watch Insights on Psychiatry on YouTube 00:00 When Psychosis May Be an Autoimmune Disease This episode is intended for psychiatrists, neurologists, and other clinicians interested in psychosis, neuroinflammation, and complex diagnostic presentations at the psychiatry–neurology interface. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||
| Closing the Revolving Door of Severe Mental Illness | 16 Feb 2026 | 00:23:41 | |
Bipin Subedi, MD, explores how health systems can better care for patients with severe mental illness who cycle between hospitals, homelessness, addiction, and the justice system. He argues that acute inpatient treatment, while essential, is rarely sufficient on its own. Preventing the revolving door of repeated hospitalizations requires psychiatry to extend beyond hospital walls and build integrated systems that follow patients into the community. Drawing on his leadership at NYU Bellevue and his background in forensic psychiatry, Dr. Subedi describes a model of care built on sustained relationships, flexibility, and continuity. He reflects on how programs like transitional housing and mobile post-discharge support can provide the “scaffolding” patients need when insight and executive function are impaired by psychosis. The conversation closes with practical guidance on strengthening medication adherence—particularly through thoughtful use of long-acting injectables—and on meeting patients where they are to advance more humane, effective care. Bipin Subedi, MD, is Associate Professor of Psychiatry at NYU Grossman School of Medicine and Chief of Psychiatry at NYU Bellevue Hospital. He is a forensic psychiatrist with prior leadership experience in New York City’s jail system. ▶️ Watch Insights on Psychiatry on YouTube 01:36 Bellevue’s Mission and Rising Clinical Complexity This episode is intended for psychiatrists, mental health clinicians, and health system leaders interested in serious mental illness and innovative models of integrated community care. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle | |||